🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research is being done to assess the therapeutic efficacy and safety o...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
Start Date
2022-03-01
Trial ID
NCT05177731
Treatments Being Tested
This is a multicenter, randomized, open-label, pragmatic low intervention c...
Status
Recruiting
Location
University Hospital Brno
Start Date
2025-02-27
Trial ID
NCT06713837
Treatments Being Tested
This is a phase 2 study to test the hypothesis that venetoclax in combinati...
Status
Suspended
Location
Valley Children's Hospital
Start Date
2023-07-25
Trial ID
NCT05955261
This screening and multi-sub-study Phase 1b/2 trial will establish a method...
Status
Recruiting
Location
Mayo Clinic Arizona
Start Date
2016-11
Trial ID
NCT03013998
Treatments Being Tested
This international, multicenter, randomized (1:1), open-label phase II/III ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-01
Trial ID
NCT07425808
Treatments Being Tested
People with acute myeloid leukemia (AML) are usually treated with chemother...
Status
Active Not Recruiting
Location
City of Hope Nat'l Medical Center
Start Date
2023-01-31
Trial ID
NCT05520567
Treatments Being Tested
This is a multicenter, randomized, controlled, open-label phase III trial e...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-30
Trial ID
NCT07407140
This phase I/II trial studies the side effects and best dose of gilteritini...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2019-12-17
Trial ID
NCT04140487
Treatments Being Tested
This phase II MyeloMATCH treatment trial compares the usual treatment of az...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2024-09-27
Trial ID
NCT06317649
CC-90009-AML-002 is an exploratory Phase 1b, open-label, multi-arm trial to...
Status
Terminated
Location
Local Institution - 104
Start Date
2020-08-05
Trial ID
NCT04336982
Treatments Being Tested